The Function of Rho-Associated Kinases ROCK1 and ROCK2 in the Pathogenesis of Cardiovascular Disease
Tóm tắt
Từ khóa
Tài liệu tham khảo
Abe, 2004, Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats, Circ. Res., 94, 385, 10.1161/01.RES.0000111804.34509.94
Abrams, 2005, Clinical practice. Chronic stable angina, N. Engl. J. Med., 352, 2524, 10.1056/NEJMcp042317
Adyshev, 2013, Ezrin/radixin/moesin proteins differentially regulate endothelial hyperpermeability after thrombin, Am. J. Physiol. Lung. Cell Mol. Physiol., 305, L240, 10.1152/ajplung.00355.2012
Adyshev, 2011, Differential involvement of ezrin/radixin/moesin proteins in sphingosine 1-phosphate-induced human pulmonary endothelial cell barrier enhancement, Cell. Signal., 23, 2086, 10.1016/j.cellsig.2011.08.003
Agrawal, 2012, Normal myofibrillar development followed by progressive sarcomeric disruption with actin accumulations in a mouse Cfl2 knockout demonstrates requirement of cofilin-2 for muscle maintenance, Hum. Mol. Genet., 21, 2341, 10.1093/hmg/dds053
Amano, 1999, The COOH terminus of Rho-kinase negatively regulates rho-kinase activity, J. Biol. Chem., 274, 32418, 10.1074/jbc.274.45.32418
Amano, 1996, Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase), J. Biol. Chem., 271, 20246, 10.1074/jbc.271.34.20246
Ark, 2010, Ouabain-induced apoptosis and Rho kinase: a novel caspase-2 cleavage site and fragment of Rock-2, Apoptosis, 15, 1494, 10.1007/s10495-010-0529-1
Baeyens, 2010, Identification and functional implication of a Rho kinase-dependent moesin-EBP50 interaction in noradrenaline-stimulated artery, Am. J. Physiol. Cell Physiol., 299, C1530, 10.1152/ajpcell.00175.2010
Barreiro, 2002, Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes, J. Cell Biol., 157, 1233, 10.1083/jcb.200112126
Barry, 2002, Cytotoxic T lymphocytes: all roads lead to death, Nat. Rev. Immunol., 2, 401, 10.1038/nri819
Biro, 2014, Targeting Rho-GTPases in immune cell migration and inflammation, Br. J. Pharmacol., 171, 5491, 10.1111/bph.12658
Blaustein, 2014, Why isn’t endogenous ouabain more widely accepted?, Am. J. Physiol. Heart Circ. Physiol., 307, H635, 10.1152/ajpheart.00404.2014
Boerma, 2008, Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin, Blood Coagul. Fibrinolysis, 19, 709, 10.1097/MBC.0b013e32830b2891
Boivin, 2012, Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1, PLoS ONE, 7, e33163, 10.1371/journal.pone.0033163
Boratko, 2013, NHERF2 is crucial in ERM phosphorylation in pulmonary endothelial cells, Cell Commun. Signal., 11, 99, 10.1186/1478-811X-11-99
Bravo-Cordero, 2013, Functions of cofilin in cell locomotion and invasion, Nat. Rev. Mol. Cell Biol., 14, 405, 10.1038/nrm3609
Chamberlain, 2010, Perforin-independent extracellular granzyme B activity contributes to abdominal aortic aneurysm, Am. J. Pathol., 176, 1038, 10.2353/ajpath.2010.090700
Chang, 2015, Constitutive phosphorylation of cardiac myosin regulatory light chain in vivo, J. Biol. Chem., 290, 10703, 10.1074/jbc.M115.642165
Chang, 2006, Activation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosis, Proc. Natl. Acad. Sci. U.S.A., 103, 14495, 10.1073/pnas.0601911103
Cheng, 2015, High glucose activates Raw264.7 macrophages through RhoA kinase-mediated signaling pathway, Cell. Signal., 27, 283, 10.1016/j.cellsig.2014.11.012
Chevrier, 2002, The Rho-associated protein kinase p160ROCK is required for centrosome positioning, J. Cell Biol., 157, 807, 10.1083/jcb.200203034
Chuang, 2013, Ser1333 phosphorylation indicates ROCKI activation, J. Biomed. Sci., 20, 83, 10.1186/1423-0127-20-83
Chuang, 2012, ROCKII Ser1366 phosphorylation reflects the activation status, Biochem. J., 443, 145, 10.1042/BJ20111839
Coleman, 2001, Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I, Nat. Cell Biol., 3, 339, 10.1038/35070009
Darmellah, 2009, ERM proteins mediate the effects of Na+/H+ exchanger (NHE1) activation in cardiac myocytes, Cardiovasc. Res., 81, 294, 10.1093/cvr/cvn320
Davies, 2000, Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochem. J., 351, 95, 10.1042/bj3510095
Davis, 2001, The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation, Cell, 107, 631, 10.1016/S0092-8674(01)00586-4
Del Re, 2007, RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis, J. Biol. Chem., 282, 8069, 10.1074/jbc.M604298200
Dimopoulos, 2007, Ca2+-dependent rapid Ca2+ sensitization of contraction in arterial smooth muscle, Circ. Res., 100, 121, 10.1161/01.RES.0000253902.90489.df
Do, 2013, Rho-kinase activation in patients with heart failure, Circ. J., 77, 2542, 10.1253/circj.CJ-13-0397
Dong, 2012, Increased Rho kinase activity in congestive heart failure, Eur. J. Heart Fail., 14, 965, 10.1093/eurjhf/hfs068
Dong, 2013, A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome, Int. J. Cardiol., 167, 2813, 10.1016/j.ijcard.2012.07.007
Doran, 2004, New insights into the structure-function relationships of Rho-associated kinase: a thermodynamic and hydrodynamic study of the dimer-to-monomer transition and its kinetic implications, Biochem. J., 384, 255, 10.1042/BJ20040344
Duffy, 2009, Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord, J. Neurosci., 29, 15266, 10.1523/JNEUROSCI.4650-09.2009
Dvorsky, 2004, Structural insights into the interaction of ROCKI with the switch regions of RhoA, J. Biol. Chem., 279, 7098, 10.1074/jbc.M311911200
Eto, 2009, Regulation of cellular protein phosphatase-1 (PP1) by phosphorylation of the CPI-17 family, C-kinase-activated PP1 inhibitors, J. Biol. Chem., 284, 35273, 10.1074/jbc.R109.059972
Feng, 1999, Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase, J. Biol. Chem., 274, 37385, 10.1074/jbc.274.52.37385
Foletta, 2004, LIM kinase 1, a key regulator of actin dynamics, is widely expressed in embryonic and adult tissues, Exp. Cell Res., 294, 392, 10.1016/j.yexcr.2003.11.024
Fujioka, 1998, A new isoform of human myosin phosphatase targeting/regulatory subunit (MYPT2): cDNA cloning, tissue expression, and chromosomal mapping, Genomics, 49, 59, 10.1006/geno.1998.5222
Fukumoto, 2005, Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension, Heart, 91, 391, 10.1136/hrt.2003.029470
Funamoto, 2002, Spatial and temporal regulation of 3-phosphoinositides by PI 3-kinase and PTEN mediates chemotaxis, Cell, 109, 611, 10.1016/S0092-8674(02)00755-9
Ganguly, 2011, Adiponectin increases LPL activity via RhoA/ROCK-mediated actin remodelling in adult rat cardiomyocytes, Endocrinology, 152, 247, 10.1210/en.2010-0530
Glyn, 2003, A Rho-associated kinase mitigates reperfusion-induced change in the shape of cardiac capillary endothelial cells in situ, Cardiovasc. Res., 57, 195, 10.1016/S0008-6363(02)00616-8
Gong, 2004, VEGF treatment induces signaling pathways that regulate both actin polymerization and depolymerization, Angiogenesis, 7, 313, 10.1007/s10456-004-7960-2
Goyal, 2013, Cofilin oligomer formation occurs in vivo and is regulated by cofilin phosphorylation, PLoS ONE, 8, e71769, 10.1371/journal.pone.0071769
Grimm, 2005, Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the α1-adrenergic positive inotropic effect in human atrium, Cardiovasc. Res., 65, 211, 10.1016/j.cardiores.2004.09.019
Guilluy, 2010, The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure, Nat. Med., 16, 183, 10.1038/nm.2079
Guo, 2009, ERM protein moesin is phosphorylated by advanced glycation end products and modulates endothelial permeability, Am. J. Physiol. Heart Circ. Physiol., 297, H238, 10.1152/ajpheart.00196.2009
Hattori, 2004, Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice, Circulation, 109, 2234, 10.1161/01.CIR.0000127939.16111.58
Haudek, 2009, Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation, Cardiovasc. Res., 83, 511, 10.1093/cvr/cvp135
Haudek, 2006, Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice, Proc. Natl. Acad. Sci. U.S.A., 103, 18284, 10.1073/pnas.0608799103
Hunter, 2009, Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway, J. Mol. Cell. Cardiol., 47, 810, 10.1016/j.yjmcc.2009.09.012
Iizuka, 2012, Distinct distribution and localization of Rho-kinase in mouse epithelial, muscle and neural tissues, Cell Struct. Funct., 37, 155, 10.1247/csf.12018
Ikeda, 2014, Crucial role of rho-kinase in pressure overload-induced right ventricular hypertrophy and dysfunction in mice, Arterioscler. Thromb. Vasc. Biol., 34, 1260, 10.1161/ATVBAHA.114.303320
Ikenoya, 2002, Inhibition of rho-kinase-induced myristoylated alanine-rich C kinase substrate (MARCKS) phosphorylation in human neuronal cells by H-1152, a novel and specific Rho-kinase inhibitor, J. Neurochem., 81, 9, 10.1046/j.1471-4159.2002.00801.x
Ishikura, 2006, Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension, Circ. J., 70, 174, 10.1253/circj.70.174
Ishizaki, 1996, The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase, EMBO J., 15, 1885, 10.1002/j.1460-2075.1996.tb00539.x
Ishizaki, 1997, p160ROCK, a Rho-associated coiled-coil forming protein kinase, works downstream of Rho and induces focal adhesions, FEBS Lett., 404, 118, 10.1016/S0014-5793(97)00107-5
Ishizaki, 2000, Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases, Mol. Pharmacol., 57, 976
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group., 1995, ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction, Lancet, 345, 669, 10.1016/S0140-6736(95)90865-X
Iskratsch, 2013, Two distinct phosphorylation events govern the function of muscle FHOD3, Cell. Mol. Life Sci., 70, 893, 10.1007/s00018-012-1154-7
Jacobs, 2006, The structure of dimeric ROCK I reveals the mechanism for ligand selectivity, J. Biol. Chem., 281, 260, 10.1074/jbc.M508847200
Jeong, 2010, AFos inhibits phenylephrine-mediated contractile dysfunction by altering phospholamban phosphorylation, Am. J. Physiol. Heart Circ. Physiol., 298, H1719, 10.1152/ajpheart.00937.2009
Julian, 2014, Rho-associated coiled-coil containing kinases (ROCK): structure, regulation, and functions, Small GTPases, 5, e29846, 10.4161/sgtp.29846
Kandabashi, 2000, Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1β, Circulation, 101, 1319, 10.1161/01.CIR.101.11.1319
Kang, 2007, Phosphorylation of Rho-associated kinase (Rho-kinase/ROCK/ROK) substrates by protein kinases A and C, Biochimie, 89, 39, 10.1016/j.biochi.2006.08.003
Katoh, 2001, Rho-kinase–mediated contraction of isolated stress fibers, J. Cell Biol., 153, 569, 10.1083/jcb.153.3.569
Katsumata, 1997, Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1β, Circulation, 96, 4357, 10.1161/01.CIR.96.12.4357
Kawabata, 2004, Interaction of Rho-kinase with myosin II at stress fibres, Genes Cells, 9, 653, 10.1111/j.1356-9597.2004.00749.x
Kawano, 1999, Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo, J. Cell Biol., 147, 1023, 10.1083/jcb.147.5.1023
Kishi, 2005, Rho-kinase inhibitor improves increased vascular resistance and impaired vasodilation of the forearm in patients with heart failure, Circulation, 111, 2741, 10.1161/CIRCULATIONAHA.104.510248
Kobayashi, 2002, Critical role of Rho-kinase pathway for cardiac performance and remodeling in failing rat hearts, Cardiovasc. Res., 55, 757, 10.1016/S0008-6363(02)00457-1
Kosako, 1999, Specific accumulation of Rho-associated kinase at the cleavage furrow during cytokinesis: cleavage furrow-specific phosphorylation of intermediate filaments, Oncogene, 18, 2783, 10.1038/sj.onc.1202633
Koyama, 2000, Phosphorylation of CPI-17, an inhibitory phosphoprotein of smooth muscle myosin phosphatase, by Rho-kinase, FEBS Lett., 475, 197, 10.1016/S0014-5793(00)01654-9
Kureishi, 1997, Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation, J. Biol. Chem., 272, 12257, 10.1074/jbc.272.19.12257
Kuwahara, 1999, The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes–possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy, FEBS Lett., 452, 314, 10.1016/S0014-5793(99)00680-8
Lee, 2009, Targeted disruption of ROCK1 causes insulin resistance in vivo, J. Biol. Chem., 284, 11776, 10.1074/jbc.C900014200
Lee, 2008, Regulation of RhoA-dependent ROCKII activation by Shp2, J. Cell Biol., 181, 999, 10.1083/jcb.200710187
Lee, 2010, Src-dependent phosphorylation of ROCK participates in regulation of focal adhesion dynamics, J. Cell Sci., 123, 3368, 10.1242/jcs.071555
Leung, 1996, The p160 RhoA-binding kinase ROKα is a member of a kinase family and is involved in the reorganization of the cytoskeleton, Mol. Cell. Biol., 16, 5313, 10.1128/MCB.16.10.5313
Leung, 1995, A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes, J. Biol. Chem., 270, 29051, 10.1074/jbc.270.49.29051
Lin, 2003, Rho-ROCK-LIMK-cofilin pathway regulates shear stress activation of sterol regulatory element binding proteins, Circ. Res., 92, 1296, 10.1161/01.RES.0000078780.65824.8B
Liu, 2008, A method for measuring Rho kinase activity in tissues and cells, Methods Enzymol., 439, 181, 10.1016/S0076-6879(07)00414-4
Lowery, 2007, Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrate, EMBO J., 26, 2262, 10.1038/sj.emboj.7601683
Ma, 2006, Interaction between ROCK II and nucleophosmin/B23 in the regulation of centrosome duplication, Mol. Cell. Biol., 26, 9016, 10.1128/MCB.01383-06
Maekawa, 1999, Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase, Science, 285, 895, 10.1126/science.285.5429.895
Mahmarian, 1998, Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized, double-blind, placebo-controlled trial, Circulation, 97, 2017, 10.1161/01.CIR.97.20.2017
Maruhashi, 2015, Exogenous nitric oxide inhibits Rho-associated kinase activity in patients with angina pectoris: a randomized controlled trial, Hypertens. Res., 38, 485, 10.1038/hr.2015.24
Masumoto, 2001, Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans, Hypertension, 38, 1307, 10.1161/hy1201.096541
Masumoto, 2002, Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina, Circulation, 105, 1545, 10.1161/hc1002.105938
Matsui, 1996, Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho, EMBO J., 15, 2208, 10.1002/j.1460-2075.1996.tb00574.x
Matsui, 1998, Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association, J. Cell Biol., 140, 647, 10.1083/jcb.140.3.647
Matsumoto, 2004, Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms, Arterioscler. Thromb. Vasc. Biol., 24, 181, 10.1161/01.ATV.0000105053.46994.5B
Moriki, 2004, RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats, Hypertens. Res., 27, 263, 10.1291/hypres.27.263
Mukai, 2001, Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension, FASEB J., 15, 1062, 10.1096/fj.00-0735fje
Nakagawa, 1996, ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice, FEBS Lett., 392, 189, 10.1016/0014-5793(96)00811-3
Nakamura, 1999, Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies. Multicenter Myocardial Ischemia Research Group, Am. Heart J., 138, 577, 10.1016/S0002-8703(99)70163-8
Nicolaou, 2009, Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology, J. Mol. Cell. Cardiol., 47, 365, 10.1016/j.yjmcc.2009.05.010
Noma, 2005, Smoking, endothelial function, and Rho-kinase in humans, Arterioscler. Thromb. Vasc. Biol., 25, 2630, 10.1161/01.ATV.0000189304.32725.bd
Noma, 2008, ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury, J. Clin. Invest., 118, 1632, 10.1172/JCI29226
Ocaranza, 2011, Markedly increased Rho-kinase activity in circulating leukocytes in patients with chronic heart failure, Am. Heart J., 161, 931, 10.1016/j.ahj.2011.01.024
Okamoto, 2006, Characterization and function of MYPT2, a target subunit of myosin phosphatase in heart, Cell. Signal., 18, 1408, 10.1016/j.cellsig.2005.11.001
Okamoto, 2013, FHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2, FASEB J., 27, 1439, 10.1096/fj.12-217018
Oudit, 2004, The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease, J. Mol. Cell. Cardiol., 37, 449, 10.1016/j.yjmcc.2004.05.015
Pelosi, 2007, ROCK2 and its alternatively spliced isoform ROCK2m positively control the maturation of the myogenic program, Mol. Cell. Biol., 27, 6163, 10.1128/MCB.01735-06
Pestonjamasp, 1995, Moesin, ezrin, and p205 are actin-binding proteins associated with neutrophil plasma membranes, Mol. Biol. Cell, 6, 247, 10.1091/mbc.6.3.247
Pinner, 2008, PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE, Nat. Cell Biol., 10, 127, 10.1038/ncb1675
Qiao, 2014, Myosin phosphatase target subunit 1 (MYPT1) regulates the contraction and relaxation of vascular smooth muscle and maintains blood pressure, J. Biol. Chem., 289, 22512, 10.1074/jbc.M113.525444
Rajashree, 2005, Modulation of myosin phosphatase targeting subunit and protein phosphatase 1 in the heart, Am. J. Physiol. Heart Circ. Physiol., 289, H1736, 10.1152/ajpheart.00318.2004
Rankinen, 2008, A major haplotype block at the rho-associated kinase 2 locus is associated with a lower risk of hypertension in a recessive manner: the HYPGENE study, Hypertens. Res., 31, 1651, 10.1291/hypres.31.1651
Riento, 2003, RhoE binds to ROCK I and inhibits downstream signaling, Mol. Cell. Biol., 23, 4219, 10.1128/MCB.23.12.4219-4229.2003
Riento, 2005, RhoE function is regulated by ROCK I-mediated phosphorylation, EMBO J., 24, 1170, 10.1038/sj.emboj.7600612
Rikitake, 2005a, Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection, Stroke, 36, 2251, 10.1161/01.STR.0000181077.84981.11
Rikitake, 2005b, Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/– haploinsufficient mice, Circulation, 112, 2959, 10.1161/CIRCULATIONAHA.105.584623
Riou, 2013, 14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins, Cell, 153, 640, 10.1016/j.cell.2013.03.044
Riou, 2010, Rnd proteins: multifunctional regulators of the cytoskeleton and cell cycle progression, Bioessays, 32, 986, 10.1002/bies.201000060
Romero, 2008, Diabetes-induced coronary vascular dysfunction involves increased arginase activity, Circ. Res., 102, 95, 10.1161/CIRCRESAHA.107.155028
Saito, 2011, Granzyme B as a novel factor involved in cardiovascular diseases, J. Cardiol., 57, 141, 10.1016/j.jjcc.2010.10.001
Sapet, 2006, Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2, Blood, 108, 1868, 10.1182/blood-2006-04-014175
Sasaki, 2002, The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway, Pharmacol. Ther., 93, 225, 10.1016/S0163-7258(02)00191-2
Schober, 2005, Mechanisms of monocyte recruitment in vascular repair after injury, Antioxid. Redox Signal., 7, 1249, 10.1089/ars.2005.7.1249
Sebbagh, 2005, Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner, J. Exp. Med., 201, 465, 10.1084/jem.20031877
Sebbagh, 2001, Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing, Nat. Cell Biol., 3, 346, 10.1038/35070019
Seko, 2003, Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle, Circ. Res., 92, 411, 10.1161/01.RES.0000059987.90200.44
Sheikh, 2012, Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease, J. Clin. Invest., 122, 1209, 10.1172/JCI61134
Shi, 2008, Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy, J. Mol. Cell. Cardiol., 44, 551, 10.1016/j.yjmcc.2007.11.018
Shi, 2010, ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice, J. Mol. Cell. Cardiol., 49, 819, 10.1016/j.yjmcc.2010.08.008
Shibata, 2001, Role of Rho-associated kinase in neointima formation after vascular injury, Circulation, 103, 284, 10.1161/01.CIR.103.2.284
Shibata, 2003, Rho-kinase inhibition reduces neointima formation after vascular injury by enhancing Bax expression and apoptosis, J. Cardiovasc. Pharmacol., 42, S43, 10.1097/00005344-200312001-00011
Shibuya, 2005, Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial, J. Neurol. Sci., 238, 31, 10.1016/j.jns.2005.06.003
Shimizu, 2013, Crucial role of ROCK2 in vascular smooth muscle cells for hypoxia-induced pulmonary hypertension in mice, Arterioscler. Thromb. Vasc. Biol., 33, 2780, 10.1161/ATVBAHA.113.301357
Shimizu, 2003, Parallel coiled-coil association of the RhoA-binding domain in Rho-kinase, J. Biol. Chem., 278, 46046, 10.1074/jbc.M306458200
Shimizu, 2005, ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles, J. Cell Biol., 168, 941, 10.1083/jcb.200411179
Shimokawa, 2002, Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter study, J. Cardiovasc. Pharmacol., 40, 751, 10.1097/00005344-200211000-00013
Shimokawa, 1999, Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm, Cardiovasc. Res., 43, 1029, 10.1016/S0008-6363(99)00144-3
Sin, 1998, RhoA-binding kinase α translocation is facilitated by the collapse of the vimentin intermediate filament network, Mol. Cell. Biol., 18, 6325, 10.1128/MCB.18.11.6325
Smith, 2013, Rho-Kinase activity and cutaneous vasoconstriction is upregulated in essential hypertensive humans, Microvasc. Res., 87, 58, 10.1016/j.mvr.2013.02.005
Soga, 2011, Rho-associated kinase activity, endothelial function, and cardiovascular risk factors, Arterioscler. Thromb. Vasc. Biol., 31, 2353, 10.1161/ATVBAHA.111.227892
Soliman, 2015, Partial deletion of ROCK2 protects mice from high fat diet-induced cardiac insulin resistance and contractile dysfunction, Am. J. Physiol. Heart Circ. Physiol., 309, H70, 10.1152/ajpheart.00664.2014
Stroeken, 2006, Integrin cytoplasmic domain-associated protein-1 (ICAP-1) interacts with the ROCK-I kinase at the plasma membrane, J. Cell. Physiol., 208, 620, 10.1002/jcp.20699
Subramanian, 2015, Cofilin-2 phosphorylation and sequestration in myocardial aggregates: novel pathogenetic mechanisms for idiopathic dilated cardiomyopathy, J. Am. Coll. Cardiol., 65, 1199, 10.1016/j.jacc.2015.01.031
Suematsu, 2001, α1-Adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts, Am. J. Physiol. Heart Circ. Physiol., 281, H637, 10.1152/ajpheart.2001.281.2.H637
Sun, 2008, Air pollution exposure potentiates hypertension through reactive oxygen species-mediated activation of Rho/ROCK, Arterioscler. Thromb. Vasc. Biol., 28, 1760, 10.1161/ATVBAHA.108.166967
Tanaka, 2006, Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase, J. Biol. Chem., 281, 15320, 10.1074/jbc.M510954200
Thumkeo, 2003, Targeted disruption of the mouse rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death, Mol. Cell. Biol., 23, 5043, 10.1128/MCB.23.14.5043-5055.2003
Thumkeo, 2005, ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo, Genes Cells, 10, 825, 10.1111/j.1365-2443.2005.00882.x
Tousoulis, 2013, Diabetes mellitus-associated vascular impairment: novel circulating biomarkers and therapeutic approaches, J. Am. Coll. Cardiol., 62, 667, 10.1016/j.jacc.2013.03.089
Tsounapi, 2012, Fasudil improves the endothelial dysfunction in the aorta of spontaneously hypertensive rats, Eur. J. Pharmacol., 691, 182, 10.1016/j.ejphar.2012.07.016
Velasco, 2002, Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1M at Thr850 induces its dissociation from myosin, FEBS Lett., 527, 101, 10.1016/S0014-5793(02)03175-7
Vemula, 2010, ROCK1 functions as a suppressor of inflammatory cell migration by regulating PTEN phosphorylation and stability, Blood, 115, 1785, 10.1182/blood-2009-08-237222
Vicari, 2005, Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial, J. Am. Coll. Cardiol., 46, 1803, 10.1016/j.jacc.2005.07.047
Vlasblom, 2009, RhoA-ROCK signaling is involved in contraction-mediated inhibition of SERCA2a expression in cardiomyocytes, Pflugers. Arch., 458, 785, 10.1007/s00424-009-0659-x
Wen, 2008, Structure basis and unconventional lipid membrane binding properties of the PH-C1 tandem of rho kinases, J. Biol. Chem., 283, 26263, 10.1074/jbc.M803417200
Wirth, 2008, G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension, Nat. Med., 14, 64, 10.1038/nm1666
Xie, 2006, Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells, Cardiovasc. Res., 69, 491, 10.1016/j.cardiores.2005.11.002
Xie, 2015, Smooth-muscle BMAL1 participates in blood pressure circadian rhythm regulation, J. Clin. Invest., 125, 324, 10.1172/JCI76881
Yamaguchi, 2006, Molecular mechanism for the regulation of rho-kinase by dimerization and its inhibition by fasudil, Structure, 14, 589, 10.1016/j.str.2005.11.024
Yanazume, 2002, Rho/ROCK pathway contributes to the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophy, J. Biol. Chem., 277, 8618, 10.1074/jbc.M107924200
Yang, 2012, Mechanism of fibrotic cardiomyopathy in mice expressing truncated Rho-associated coiled-coil protein kinase 1, FASEB J., 26, 2105, 10.1096/fj.11-201319
Yang, 2015, Genetic deletion of Rnd3/RhoE results in mouse heart calcium leakage through upregulation of protein kinase A signaling, Circ. Res., 116, e1, 10.1161/CIRCRESAHA.116.304940
Yao, 2013, Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout, Cardiovasc. Res., 97, 509, 10.1093/cvr/cvs371
Ye, 2009, Inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA/Rho kinase pathway, FEBS Lett., 583, 2997, 10.1016/j.febslet.2009.08.034
Yoneda, 2005, The Rho kinases I and II regulate different aspects of myosin II activity, J. Cell Biol., 170, 443, 10.1083/jcb.200412043
Yue, 2014, Rnd3 haploinsufficient mice are predisposed to hemodynamic stress and develop apoptotic cardiomyopathy with heart failure, Cell Death Dis., 5, e1284, 10.1038/cddis.2014.235
Zhang, 2014, p38MAPK, Rho/ROCK and PKC pathways are involved in influenza-induced cytoskeletal rearrangement and hyperpermeability in PMVEC via phosphorylating ERM, Virus Res., 192, 6, 10.1016/j.virusres.2014.07.027
Zhang, 2006, Targeted deletion of ROCK1 protects the heart against pressure overload by inhibiting reactive fibrosis, FASEB J., 20, 916, 10.1096/fj.05-5129com